XML 70 R10.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Revenue
 6 Months Ended
Jun. 30, 2024
Revenue from Contract with Customer [Abstract]  
Revenue PRODUCT REVENUE, NET
During the three and six months ended June 30, 2024, the Company recorded $0.7 million of gross revenue from the sale of its product to its customer. The Company also recorded an estimate of variable consideration as a provision against gross revenue resulting in net revenue of $0.6 million for the three and six months ended June 30, 2024.

The following table summarizes the activity in each of the product reserve accounts for the six months ended June 30, 2024.
(in thousands)Rebates and DiscountsCo-Pay AssistanceProduct ReturnsTotal
Beginning balance at December 31, 2023$— $— $— $— 
Provision related to revenue in the three and six month period ended June 30, 202444 35 92 171 
Credits and payments made during the period(21)(20)— (41)
Balance as of June 30, 2024$23 $15 $92 $130 

The provision for contractual discounts provided to the Company’s customer is recorded as a reduction of accounts receivable. The provisions for co-pay assistance payments, contractual rebates and product returns are classified within accrued expenses.

The following table provides a rollforward of accounts receivable for the six months ended June 30, 2024. There was no activity in accounts receivable in the six months ended June 30, 2023.

(in thousands)Accounts Receivable
Beginning balance at December 31, 2023$— 
Increase in accounts receivable for drug product sales713 
Decrease in accounts receivable for cash collections(713)
Balance as of June 30, 2024$—